|
Donna L. LaVoie, President & CEO print page
Donna L. LaVoie, President of LaVoie Strategic Communications Group, Inc., has more than 15 years experience in corporate communications and investor relations. As a strategic business partner, her expertise is in providing senior-level corporate communications and investor relations counsel to executive management of health care and technology companies.
Her unique approach is based on building credibility for management teams with the financial community and providing corporate positioning focused on building long-term, sustainable value. She brings knowledge of all aspects of the corporate marketing effort and the integration of investor relations in the overall mix of those efforts. One of her core strengths is the development of strong relationships with members of the financial community and press.
Ms. LaVoie is a communications and investor relations expert, having spent her career in senior communications and investor relations roles at various technology and biotechnology firms. Prior to launching LaVoie Strategic Communications Group, Inc., Ms. LaVoie held the position of Vice President, Corporate & Strategic Marketing at Stream International, Vice President of Investor Relations at Cambridge Technology Partners, and senior communications and investor relations roles at Ergo Science Corporation, GenRad, Inc., Alkermes, Inc., and Genzyme Corporation.
Ms. LaVoie is a frequent speaker and has been published on a variety of subjects including crisis communications, web-based investor relations strategies, targeting and international investor relations. She holds a Bachelor of Science in Management from Lesley College. She is on the Board of The Salvation Army and is a member of the National Investor Relations Institute Ms. LaVoie is Co-Chair of the Communications Committee for the Mass Biotech Council.
| 